BACKGROUND: Genetic variants of nucleotide-binding oligomerization domain 2 (NOD2) lead to aberrant microbial recognition and can cause chronic inflammatory diseases in patients with Crohn's disease (CD). METHODS: We utilized gene-specific siRNA mediated knockdown and expression of guanine nucleotide exchange factor H1 (GEF-H1) in wildtype, Rip2-, and Nod2-deficient macrophages, HCT-116 and HEK 293 cells to determine the role of GEF-H1 in NOD2 and Rip2-mediated NF-κB-dependent induction of proinflammatory cytokine expression. Confocal microscopy was used to determine subcellular distribution of GEF-H1, Rip2, and NOD2. RESULTS: We identified GEF-H1 as an unexpected component of innate immune regulation during microbial pattern recognition by NOD2. Surprisingly, GEF-H1-mediated the activation of Rip2 during signaling by NOD2, but not in the presence of the 3020 insC variant of NOD2 associated with CD. GEF-H1 functioned downstream of NOD2 as part of Rip2-containing signaling complexes and was responsible for phosphorylation of Rip2 by Src tyrosine kinase. Rip2 variants lacking the tyrosine target of GEF-H1-mediated phosphorylation were unable to mediate NF-κB activation in Rip2-deficient macrophages and failed to transduce NOD2 signaling. GEF-H1 is required downstream of NOD2 as part of Rip2-containing signaling complexes for the activation of innate immune responses. CONCLUSIONS: GEF-H1 connects tyrosine kinase function to NOD-like receptor signaling and is fundamental to the regulation of microbial recognition by ubiquitous innate immune mechanisms mediated by Rip2 kinase.
BACKGROUND: Genetic variants of nucleotide-binding oligomerization domain 2 (NOD2) lead to aberrant microbial recognition and can cause chronic inflammatory diseases in patients with Crohn's disease (CD). METHODS: We utilized gene-specific siRNA mediated knockdown and expression of guanine nucleotide exchange factor H1 (GEF-H1) in wildtype, Rip2-, and Nod2-deficient macrophages, HCT-116 and HEK 293 cells to determine the role of GEF-H1 in NOD2 and Rip2-mediated NF-κB-dependent induction of proinflammatory cytokine expression. Confocal microscopy was used to determine subcellular distribution of GEF-H1, Rip2, and NOD2. RESULTS: We identified GEF-H1 as an unexpected component of innate immune regulation during microbial pattern recognition by NOD2. Surprisingly, GEF-H1-mediated the activation of Rip2 during signaling by NOD2, but not in the presence of the 3020 insC variant of NOD2 associated with CD. GEF-H1 functioned downstream of NOD2 as part of Rip2-containing signaling complexes and was responsible for phosphorylation of Rip2 by Srctyrosine kinase. Rip2 variants lacking the tyrosine target of GEF-H1-mediated phosphorylation were unable to mediate NF-κB activation in Rip2-deficient macrophages and failed to transduce NOD2 signaling. GEF-H1 is required downstream of NOD2 as part of Rip2-containing signaling complexes for the activation of innate immune responses. CONCLUSIONS:GEF-H1 connects tyrosine kinase function to NOD-like receptor signaling and is fundamental to the regulation of microbial recognition by ubiquitous innate immune mechanisms mediated by Rip2 kinase.
Authors: P Rahman; S Bartlett; F Siannis; F J Pellett; V T Farewell; L Peddle; C T Schentag; C A Alderdice; S Hamilton; M Khraishi; Y Tobin; D Hefferton; D D Gladman Journal: Am J Hum Genet Date: 2003-07-23 Impact factor: 11.025
Authors: Felix S Oppermann; Florian Gnad; Jesper V Olsen; Renate Hornberger; Zoltán Greff; György Kéri; Matthias Mann; Henrik Daub Journal: Mol Cell Proteomics Date: 2009-04-15 Impact factor: 5.911
Authors: Amlan Biswas; Yuen-Joyce Liu; Liming Hao; Atsushi Mizoguchi; Nita H Salzman; Charles L Bevins; Koichi S Kobayashi Journal: Proc Natl Acad Sci U S A Date: 2010-08-02 Impact factor: 11.205
Authors: Wei Duan; Amit K Mehta; Joao G Magalhaes; Steven F Ziegler; Chen Dong; Dana J Philpott; Michael Croft Journal: J Allergy Clin Immunol Date: 2010-11-04 Impact factor: 10.793
Authors: Kristina A Archer; Florence Ader; Koichi S Kobayashi; Richard A Flavell; Craig R Roy Journal: Infect Immun Date: 2010-03-29 Impact factor: 3.441
Authors: J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas Journal: Nature Date: 2001-05-31 Impact factor: 49.962
Authors: Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho Journal: Nature Date: 2001-05-31 Impact factor: 49.962
Authors: Dana J Philpott; Matthew T Sorbara; Susan J Robertson; Kenneth Croitoru; Stephen E Girardin Journal: Nat Rev Immunol Date: 2013-12-13 Impact factor: 53.106
Authors: Wenliang Pan; Kamalpreet Nagpal; Abel Suárez-Fueyo; Andrew Ferretti; Nobuya Yoshida; Maria G Tsokos; George C Tsokos Journal: J Immunol Date: 2021-03-24 Impact factor: 5.422
Authors: Shuai Li; Ee Ming Wong; Minh Bui; Tuong L Nguyen; Ji-Hoon Eric Joo; Jennifer Stone; Gillian S Dite; Pierre-Antoine Dugué; Roger L Milne; Graham G Giles; Richard Saffery; Melissa C Southey; John L Hopper Journal: Int J Obes (Lond) Date: 2018-05-17 Impact factor: 5.095